Identifying factors affecting tolerance of ureteral double-J stents
Risk Factors for Poor Tolerance of Ureteral Double-J Stent
This study is trying to find out what makes it hard for people to tolerate ureteral double-J stents so that doctors can help improve their experience and outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT06815107 on ClinicalTrials.gov |
What this trial studies
This study aims to identify predictive factors that contribute to poor tolerance of ureteral double-J stents, which are commonly used in emergency treatments or as preparation for endoscopy following colic nephritis. The research involves administering a questionnaire and the USSQ survey to assess urinary symptoms and the impact of the stent on patients' daily activities. By understanding these factors, the study seeks to improve patient management and outcomes related to stent placement.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who require ureteral double-J stenting.
Not a fit: Patients under 18 years old, those with understanding disorders, or those who have long-term stenting or active cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management strategies for patients undergoing ureteral double-J stenting, enhancing their quality of life.
How similar studies have performed: While the specific approach of identifying tolerance factors for ureteral double-J stents may be novel, similar studies have shown success in understanding patient experiences with other medical devices.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient over 18 years old * patient who need Ureteral Double-J Stenting Exclusion Criteria: * patient under 18 years old, * Iterative change, * understanding disorder, * inability to answer the questionnaire, * refusal of the patient, * long-term Ureteral Double-J Stenting (more than 6 month), * active cancer.
Where this trial is running
Amiens
- CHU Amiens-Picardie — Amiens, France (Recruiting)
Study contacts
- Study coordinator: Philippe De Sousa, MD
- Email: desousa.philippe@chu-amiens.fr
- Phone: 33+322455775
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.